Results 201 to 210 of about 39,803 (247)
Some of the next articles are maybe not open access.
The Insulinotropic Action of Gastric Inhibitory Polypeptide
Canadian Journal of Physiology and Pharmacology, 1975The effect of highly purified gastric inhibitory polypeptide (GIP) on immunoreactive insulin (IRI) secretion in the conscious fasted dog was investigated. Significant increases in IRI release were observed with intravenous administration of three different doses of GIP. These were accompanied by depression in fasting serum-glucose levels.
R A, Pederson, H E, Schubert, J C, Brown
openaire +2 more sources
Identification and Actions of Gastric Inhibitory Polypeptide
1975Publisher Summary This chapter gives an overview of the identification and actions of gastric inhibitory polypeptide (GIP). It describes an experiment in which it is concluded that exogenous or endogenous GIP is capable of insulinotropic effects in normal man and can lead to substantial acceleration of the disposal of glucose.
J C, Brown +3 more
openaire +2 more sources
Gastric inhibitory polypeptide does not inhibit gastric emptying in humans
American Journal of Physiology-Endocrinology and Metabolism, 2004The insulinotropic gut hormone gastric inhibitory polypeptide (GIP) has been demonstrated to inhibit gastric acid secretion and was proposed to possess “enterogastrone” activity. GIP effects on gastric emptying have not yet been studied. Fifteen healthy male volunteers (23.9 ± 3.3 yr, body mass index 23.7 ± 2.3 kg/m2) were studied with the intravenous
Meier, Juris J +7 more
openaire +3 more sources
Gastric inhibitory polypeptide and gastric acid secretion in pregnant rats
Placenta, 1995The effects of pregnancy on the basal and pentagastrin-stimulated gastric acid secretion and the level of plasma gastric inhibitory polypeptide (GIP) in rats were studied on pentobarbital-anaesthetized non-pregnant rats and rats in the 1st, 2nd, or 3rd week of gestation. Acid output was determined by titration of the gastric perfusate.
T S, Chen +9 more
openaire +2 more sources
Glucose-dependent insulinotropic polypeptide (Gastric Inhibitory Polypeptide; GIP).
Vitamins and hormones, 2009Glucose-dependent insulinotropic polypeptide (GIP; gastric inhibitory polypeptide) is a 42 amino acid hormone that is produced by enteroendocrine K-cells and released into the circulation in response to nutrient stimulation. Both GIP and glucagon-like peptide-1 (GLP-1) stimulate insulin secretion in a glucose-dependent manner and are thus classified as
Christopher H S, McIntosh +2 more
openaire +1 more source
Gastric inhibitory polypeptide receptor
AfCS-Nature Molecule Pages, 2007Dieter Hoersch, Joerg Schrader
openaire +1 more source
Integrative oncology: Addressing the global challenges of cancer prevention and treatment
Ca-A Cancer Journal for Clinicians, 2022Jun J Mao,, Msce +2 more
exaly
[Gastric inhibitory polypeptide (GIP) (author's transl].
Zeitschrift fur Gastroenterologie, 1978Gastric inhibitory polypeptide (GIP) is released from the duodenum and jejunum following the ingestion of glucose, fat and amino acids. This hormone potentiates the glucose-induced insulin release from the beta-cells of the pancreas. The role of GIP as "incretin" is discussed.
R, Ebert, U, Finke
openaire +1 more source